Among other infection control practices for hemodialysis, surveyors will be observing water and dialysate testing, medication storage, preparation and administration, and “patient placement in full view of staff during dialysis treatment,” according to a Joint Commission official.
This type of error could happen anywhere given current system vulnerabilities frequently found in hospitals, particularly when using automated dispensing cabinets. In fact, ISMP has observed many of the same system vulnerabilities in other hospitals, and they are frequently at the root of a variety of medication errors reported to the ISMP National Medication Errors Reporting Program.
Although individuals on the panel expressed slightly differing views overall, they agreed that AI in healthcare is an overhyped concept inappropriately attributed to programs that do not fit any reasonable definition of AI tools.
For nearly a decade, healthcare professionals and medical device manufacturers have been aware that medical devices, including insulin pumps and pacemakers, can be hacked. While some strides have been made in securing these types of devices, the growing interconnectivity of smart medical devices continues to outpace security.
The CDC issued a bulletin urging hospitals and other healthcare facilities to remain prepared for infectious disease outbreaks.
The recent study, published in Health Affairs and LDI Research Brief, found clinician visits to hospital-discharged patients at SNFs were strongly associated with readmission and mortality rates.
The proposed rule establishes a process AOs with Medicare-approved accreditation programs must follow if there is a sale, transfer, and/or purchase of assets related to the ownership of an AO.
The recent research found only 46% of emergency department sepsis patients received antibiotics within 3 hours of ED arrival when the emergency room was crowded compared to 63% receiving timely antibiotics when the ER was not crowded.
The study, published last month in JAMA Internal Medicine, found that 37.5% of the 6,539 patients reviewed were receiving the anticoagulant warfarin and aspirin without a clear indication, and that these patients were at a significant increase in adverse outcomes.
The HHS Division of Research, Innovation, and Ventures (DRIVe), which operates under the Biomedical Advanced Research and Development Authority (BARDA), is seeking medical product developers, research teams, and companies offering disruptive solutions to health security threats.